Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeremy David Fehr Insider Profile
4 Followers
Jeremy David Fehr, Director at Marvel Biosciences Corp, holds 700.00K shares in Marvel Biosciences Corp (Ticker: TSE:MRVL). Most recently, Jeremy David Fehr Bought C$100,000 shares of Marvel Biosciences Corp on Jul 30, 2022 for an estimated value of 10.00K.
Jeremy David Fehr has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jeremy David Fehr's holdings
Insider Roles
Director
Roles that Jeremy David Fehr holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jeremy David Fehr
Jeremy David Fehr's Trading History
List of latest transactions for each holding click on a transaction to see Jeremy David Fehr's performance on stock
You May Also Like
Jeremy David Fehr insider profile FAQ
What is the percentage of profitable transactions made by Jeremy David Fehr?
The percentage of profitable transactions made by Jeremy David Fehr is ―.
What is the average return per transaction made by Jeremy David Fehr?
The average return per transaction made by Jeremy David Fehr is ―.
What stocks does Jeremy David Fehr hold?
Jeremy David Fehr holds: TSE:MRVL stocks.
What was Jeremy David Fehr’s latest transaction?
Jeremy David Fehr latest transaction was an Informative Buy of C$10.00K.
What was Jeremy David Fehr's most profitable transaction?
Jeremy David Fehr’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jeremy David Fehr's role in Marvel Biosciences Corp?
Jeremy David Fehr's role in Marvel Biosciences Corp is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.